FGAM
IBIO icon

Financial Gravity Asset Management’s iBio IBIO Stock Holding History

Financial Gravity Asset Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
2
– – ﹤0.01% 936
2025
Q4 		$4 Hold
2
– – ﹤0.01% 756
2025
Q3 		$2 Buy
+2
New +$2 ﹤0.01% 962
2025
Q1 		$8 Buy
+2
New +$8 ﹤0.01% 1039
2024
Q2 		$4 Hold
2
– – ﹤0.01% 1379
2024
Q1 		$3 Hold
2
– – ﹤0.01% 1172
2023
Q4 		$3 Buy
+2
New +$9 ﹤0.01% 1327

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Financial Gravity Asset Management's IBIO Position: Q1 2026 in Review

Financial Gravity Asset Management held its iBio (IBIO) position steady in Q1 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Financial Gravity Asset Management first reported a position in IBIO in Q4 2023 and has held it in 7 quarters since. The position peaked at $8 in Q1 2025. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Financial Gravity Asset Management held 2 shares of iBio worth $4 as of Q1 2026.
  • Financial Gravity Asset Management left its iBio share count unchanged in Q1 2026.
  • iBio made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #936 holding.
  • Financial Gravity Asset Management first reported a position in iBio in Q4 2023 and has held it in 7 quarters since.
  • Financial Gravity Asset Management's iBio position peaked at $8 in Q1 2025.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.